So, you are telling me that RPC is now controlled by this buyer? I don't get it... I have no idea what fundamental analysis you are talking about as their balance sheet is a complete mess.. I haven't done deep analysis but only in last quarter they had 18k cash in had vs current debt of over 2MM... They are being cited for possible delisting and have you read their business plan for continued listing? If not its here
 http://finance.yahoo.com/news/Radient-Pharmaceuticals-iw-4170966983.html?x=0&.v=1

Here is the zest...
The business plan includes, but is not limited to, securing additional
capital through equity financing and an equity line of credit; securing
shareholder approval for various debt for equity transactions to eliminate
the majority of RPC's near- and long-term debt; monetizing RPC's ownership
in its China-based subsidiary Jade Pharmaceuticals Inc.; advancing the
international commercialization of the Company's Onko-Sure� cancer test
kits, Onko-Care cancer test services and Elleuxe skin-care product line;
and instituting a new investor relations program to promote investor buying
in RPC.

I personally don't like investing in these small caps.. been there done that and got burned once. Still, I'd like to know more. Sell me on this, will you? This is how we debate and find better investments!

BTW the FLSR you mentioned earlier is doing pretty good, very volatile tho and I don't even want to venture to guess what the market will be doing in next couple of days as it is simply impossible.